TARCIC NORA,BAR-ZOHAR DAN,KOFLER DINA,TARCIC Nora,BAR-ZOHAR Dan,KOFLER Dina
申请号：
SI201031018
公开号：
SI2442651T1
申请日:
2010.06.18
申请国别(地区):
SI
年份:
2015
代理人:
摘要：
The subject invention provides for methods of reducing the relapse rate and/or reducing the accumulation of physical disability in a relapsing-remitting multiple sclerosis human patient, the method comprising orally administering to the patient a daily dose of 0.6 mg laquinimod. The subject invention also provides for pharmaceutical oral unit dosage forms of 0.6 mg laquinimod for use in reducing the relapse rate and/or for use in reducing the accumulation of physical disability in a relapsing-remitting multiple sclerosis human patient.
